| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 27.306 | 29.982 | 148.217 | 559.279 | 543.541 | 1.419.806 | 1.898.685 | 1.614.089 | 1.999.406 |
| Total Income - EUR | 50 | 28.290 | 30.175 | 148.531 | 561.414 | 544.803 | 1.423.915 | 1.926.404 | 1.627.810 | 2.017.061 |
| Total Expenses - EUR | 18.359 | 56.619 | 55.818 | 160.125 | 506.493 | 483.024 | 1.187.403 | 1.653.792 | 1.401.295 | 1.801.054 |
| Gross Profit/Loss - EUR | -18.308 | -28.329 | -25.643 | -11.594 | 54.921 | 61.778 | 236.512 | 272.612 | 226.515 | 216.008 |
| Net Profit/Loss - EUR | -18.308 | -28.616 | -25.943 | -13.076 | 49.328 | 56.484 | 216.269 | 235.457 | 195.709 | 183.110 |
| Employees | 0 | 2 | 2 | 0 | 0 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Farmarosib Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 91.854 | 85.957 | 79.897 | 86.114 | 80.385 | 75.078 | 70.761 | 65.941 | 63.676 | 357.548 |
| Current Assets | 7.953 | 13.453 | 5.364 | 75.377 | 224.607 | 280.496 | 669.142 | 628.934 | 793.484 | 932.478 |
| Inventories | 0 | 7.402 | 0 | 4.785 | 0 | 36.298 | 63.180 | 86.892 | 109.512 | 72.436 |
| Receivables | 1.756 | 1.062 | 1.683 | 57.185 | 165.639 | 230.523 | 451.950 | 188.661 | 179.334 | 605.540 |
| Cash | 6.198 | 4.989 | 3.681 | 13.406 | 58.968 | 13.675 | 154.012 | 353.381 | 504.638 | 254.501 |
| Shareholders Funds | -21.083 | -49.484 | -74.589 | -86.297 | -35.297 | 21.857 | 237.641 | 372.447 | 567.027 | 445.417 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 120.890 | 148.894 | 159.851 | 247.787 | 340.288 | 333.717 | 502.868 | 322.428 | 293.833 | 848.550 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Farmarosib Srl